Chinese Journal of Contemporary Neurology and Neurosurgery ›› 2022, Vol. 22 ›› Issue (2): 99-103. doi: 10.3969/j.issn.1672-6731.2022.02.007

• Migraine • Previous Articles     Next Articles

Advances in acute and preventive treatment of migraine

LIN Xiao-xue1, LIU Ying-yuan1, ZHANG Shu-hua2, DONG Zhao3   

  1. 1 Grade 2021, Chinese PLA Medical School, Beijing 100853, China;
    2 Grade 2021, School of Medicine, Nankai University, Tianjin 300071, China;
    3 Department of Neurology, International Headache Center, Chinese PLA General Hospital, Beijing 100853, China
  • Received:2022-02-18 Online:2022-02-25 Published:2022-03-04
  • Supported by:
    This study was supported by the National Natural Science Foundation of China (No. 81771200).

偏头痛急性期和预防性治疗进展

林晓雪1, 刘颖元1, 张淑华2, 董钊3   

  1. 1 100853 北京, 解放军医学院2021级;
    2 300071 天津, 南开大学医学院2021 级;
    3 100853 北京, 解放军总医院神经内科医学部国际头痛中心
  • 通讯作者: 董钊,Email:dong_zhaozhao@126.com
  • 基金资助:
    国家自然科学基金资助项目(项目编号:81771200)

Abstract: Migraine is a common and often disabling neurologic disease, its high prevalence and disability significantly impact on patients and relatives, contributing to heavy social and economic burden. However, currently available migraine treatment options are limited and are often associated with many intolerable side-effects. Therefore, it is necessary to explore new therapeutic options for migraine. This review discusses the most recent and evidence-based advances in pharmacological and non-pharmacological treatment approaches for migraine.

Key words: Migraine, Drug therapy, Serotonin receptor agonists, Calcitonin gene-related peptide, Pituitary adenylate cyclase-activating polypeptide, Antibodies, monoclonal, Acupuncture therapy, Review

摘要: 偏头痛是常见的神经系统疾病,其高患病率和所导致的失能加重患者及其家庭和社会疾病负担。然而,目前的偏头痛治疗方案并不能完全满足临床需要且常伴有各种不良反应,因此亟待新的治疗方案。本文综述近年偏头痛急性期和预防性治疗的药物治疗和非药物治疗研究进展。

关键词: 偏头痛, 药物疗法, 血清素受体激动剂, 降钙素基因相关肽, 垂体腺苷酸环化酶激活多肽, 抗体,单克隆, 针刺疗法, 综述